• Could Breaking Up Be Johnson & Johnson (JNJ)'s Salvation? More...
• Skyepharma PLC (SKYEF) Invests £5 Million, Added 40 New Jobs in Sanofi (France) (SAN.PA) Site to Produce Asthma Inhaler More...
• BioRamo Gets Incentives for 36 Fort Lauderdale Jobs More...
• Durata Therapeutics, Inc. Prices $68 Million IPO More...
• Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing More...
• The Franklin Institute Receives $2.5 Million Gift From Teva Pharmaceutical Industries Limited (TEVA) More...
• Novasep Invests £3 Million to Boost its HPAPI Manufacturing Capabilities More...
• Guardian Point Asks Sun Pharmaceutical Industries Ltd to Up Taro Pharmaceutical Industries Ltd. (TARO) Offer More...
• Chengdu Hoist Selling Animal Health Business More...
• Nestle Health Science Takes Stake in Accera, Inc. to Advance Potential of Axona® More...
• SAIC's $473 Million Aquisition to More than Double Commercial Health Care Business More...
• Purdue Pharma L.P. Ends Infinity Pharmaceuticals Inc. (INFI) Partnership, Buys $27.5 Million in Stock More...
• Array BioPharma, Inc. (ARRY) Reaches $8.5 Million Milestone in Amgen (AMGN) Diabetes Agreement More...
• Thermo Fisher Scientific (TMO) and Refine Technology Partner for Expanded Capabilities More...
• Life Technologies (LIFE) Signs Collaborative Agreement With Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies More...
• PAREXEL International (PRXL) and Korea Drug Development FundAnnounce Alliance to Accelerate Global Drug Development and Commercialization More...
• DARA BioSciences, Inc. Names Stephen Jaeger to Board More...
• DBV Technologies Welcomes Mr. Stef Koppelman as Its New General Scientific Advisor More...
• Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company (MDCO) New Business Ventures Team More...
• Novartis AG (NVS) Banks on New Drugs to Offset Generics Pressure More...
• Cost Cuts Help Actelion Ltd. (ALIOF.PK) Lift Earnings View More...
• Abbott Laboratories (ABT) 2Q Profit Beats Expectations as Humira Sales Grow More...
• Athersys, Inc. to Host Second Quarter 2012 Financial Results Call More...
• AMAG Pharmaceuticals, Inc. (AMAG) to Host Conference Call on July 26, 2012 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended June 30, 2012 More...
• Johnson & Johnson (JNJ) Escapes Class Action Suit Over Recalls More...
• Somaxon Pharmaceuticals, Inc. (SOMX) Announces Settlement of Silenor Patent Litigation With Zydus Pharmaceuticals (USA) Inc. More...
• Pfizer Inc. (PFE) Wins Price Fixing Case in Indonesia More...
• Verenium Corporation (VRNM) and Alexandria Real Estate Equities, Inc.Celebrate the Grand Opening of a New State-of-the-art Biotechnology Facility More...
• Acorda Therapeutics (ACOR) Relocates Corporate Headquarters to Ardsley Park Life Science Campus More...
• Renascions Moves into Janssen Labs More...
• European Medicines Agency Accepts Pfizer Inc. (PFE)'s BZA/CE MAA for Review More...
• ImmuCell (ICCC) Receives Effectiveness Technical Section Complete Letter From FDA for Mast Out® More...
• pSivida Corp (PSDV) Receives FDA Clearance for Pivotal Trials for Injectable Sustained-Release Micro-Insert to Treat Uveitis More...
• First Patient Treated in Angion Biomedica Corp.'s Phase II BB3 Heart Attack Clinical Trial More...
• Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients With Dry Eye Syndrome More...
• Viral Genetics Inc. (VRAL) Begins Phase 1 Clinical Trial for Ovarian Cancer More...
• Actinium Pharmaceuticals, Inc. Successfully Completes First Cohort in Multicenter Phase I/II Leukemia Trial of Actimab-A More...
• Phrixus Pharmaceuticals, Inc. Reports Positive Preclinical Results in Respiratory Disease in Duchenne Muscular Dystrophy After Subcutaneous Delivery of Carmeseal(TM) at Very Low Doses More...
• Egg Allergies Treated With Egg, University of North Carolina School of Medicine Study More...
• Harvard Medical School Study Gives First Evidence That Adult Human Lungs Can Regrow More...
• New Targeting Technology Improves Outcomes for Patients With Atrial Fibrillation, University of California, Los Angeles (UCLA), University of California, San Diego (UCSD), Indiana University Study More...
• Sleep Deprivation May Reduce Risk of PTSD According to Ben-Gurion University of the Negev Researchers More...
• Certain Heart Meds May Give Chemo a Boost, INSERM Study More...
• Skyepharma PLC (SKYEF) Invests £5 Million, Added 40 New Jobs in Sanofi (France) (SAN.PA) Site to Produce Asthma Inhaler More...
• BioRamo Gets Incentives for 36 Fort Lauderdale Jobs More...
• Durata Therapeutics, Inc. Prices $68 Million IPO More...
• Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing More...
• The Franklin Institute Receives $2.5 Million Gift From Teva Pharmaceutical Industries Limited (TEVA) More...
• Novasep Invests £3 Million to Boost its HPAPI Manufacturing Capabilities More...
• Guardian Point Asks Sun Pharmaceutical Industries Ltd to Up Taro Pharmaceutical Industries Ltd. (TARO) Offer More...
• Chengdu Hoist Selling Animal Health Business More...
• Nestle Health Science Takes Stake in Accera, Inc. to Advance Potential of Axona® More...
• SAIC's $473 Million Aquisition to More than Double Commercial Health Care Business More...
• Purdue Pharma L.P. Ends Infinity Pharmaceuticals Inc. (INFI) Partnership, Buys $27.5 Million in Stock More...
• Array BioPharma, Inc. (ARRY) Reaches $8.5 Million Milestone in Amgen (AMGN) Diabetes Agreement More...
• Thermo Fisher Scientific (TMO) and Refine Technology Partner for Expanded Capabilities More...
• Life Technologies (LIFE) Signs Collaborative Agreement With Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies More...
• PAREXEL International (PRXL) and Korea Drug Development FundAnnounce Alliance to Accelerate Global Drug Development and Commercialization More...
• DARA BioSciences, Inc. Names Stephen Jaeger to Board More...
• DBV Technologies Welcomes Mr. Stef Koppelman as Its New General Scientific Advisor More...
• Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company (MDCO) New Business Ventures Team More...
• Novartis AG (NVS) Banks on New Drugs to Offset Generics Pressure More...
• Cost Cuts Help Actelion Ltd. (ALIOF.PK) Lift Earnings View More...
• Abbott Laboratories (ABT) 2Q Profit Beats Expectations as Humira Sales Grow More...
• Athersys, Inc. to Host Second Quarter 2012 Financial Results Call More...
• AMAG Pharmaceuticals, Inc. (AMAG) to Host Conference Call on July 26, 2012 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended June 30, 2012 More...
• Johnson & Johnson (JNJ) Escapes Class Action Suit Over Recalls More...
• Somaxon Pharmaceuticals, Inc. (SOMX) Announces Settlement of Silenor Patent Litigation With Zydus Pharmaceuticals (USA) Inc. More...
• Pfizer Inc. (PFE) Wins Price Fixing Case in Indonesia More...
• Verenium Corporation (VRNM) and Alexandria Real Estate Equities, Inc.Celebrate the Grand Opening of a New State-of-the-art Biotechnology Facility More...
• Acorda Therapeutics (ACOR) Relocates Corporate Headquarters to Ardsley Park Life Science Campus More...
• Renascions Moves into Janssen Labs More...
• European Medicines Agency Accepts Pfizer Inc. (PFE)'s BZA/CE MAA for Review More...
• ImmuCell (ICCC) Receives Effectiveness Technical Section Complete Letter From FDA for Mast Out® More...
• pSivida Corp (PSDV) Receives FDA Clearance for Pivotal Trials for Injectable Sustained-Release Micro-Insert to Treat Uveitis More...
• First Patient Treated in Angion Biomedica Corp.'s Phase II BB3 Heart Attack Clinical Trial More...
• Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients With Dry Eye Syndrome More...
• Viral Genetics Inc. (VRAL) Begins Phase 1 Clinical Trial for Ovarian Cancer More...
• Actinium Pharmaceuticals, Inc. Successfully Completes First Cohort in Multicenter Phase I/II Leukemia Trial of Actimab-A More...
• Phrixus Pharmaceuticals, Inc. Reports Positive Preclinical Results in Respiratory Disease in Duchenne Muscular Dystrophy After Subcutaneous Delivery of Carmeseal(TM) at Very Low Doses More...
• Egg Allergies Treated With Egg, University of North Carolina School of Medicine Study More...
• Harvard Medical School Study Gives First Evidence That Adult Human Lungs Can Regrow More...
• New Targeting Technology Improves Outcomes for Patients With Atrial Fibrillation, University of California, Los Angeles (UCLA), University of California, San Diego (UCSD), Indiana University Study More...
• Sleep Deprivation May Reduce Risk of PTSD According to Ben-Gurion University of the Negev Researchers More...
• Certain Heart Meds May Give Chemo a Boost, INSERM Study More...
0 comments